Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Thomas Quemeneur"'
Autor:
Antoine Lafarge, Mohamed Hamidou, Matthieu Groh, Pacal Cohen, Alexandre Karras, Christian Pagnoux, Camillo Ribi, Xavier Puéchal, Benjamin Terrier, Luc Mouthon, Thomas Quemeneur, Loïc Guillevin, Maxime Samson, Adrien Joseph
Publikováno v:
Annals of the Rheumatic Diseases. 79:431-433
Reduction in cyclophosphamide cumulative dose and introduction of newer immunosuppressive drugs may reduce the malignant burden of systemic necrotising vasculitis (SNV).1 2 This study aimed to describe malignancies recorded in five randomised control
Autor:
C. Rousselin, M. Verstraete, N. Le Gouellec, Thomas Quemeneur, A. Fagart, T. Machet, G. Collet, F. Demailly, R. Ben Ticha
Publikováno v:
Annals of the Rheumatic Diseases. 80:664.1-664
Background:18F-fluorodeoxyglucose positron emission tomography with computed tomography (FDG-PET/CT) is widely used in patients with large-vessel vasculitis (1). The benefits of FDG-PET/CT in polyarteritis nodosa (PAN) has only been assessed in a few
Autor:
Olivier Aumaître, Olivier Lidove, Chahéra Khouatra, Olivier Decaux, Pascal Cohen, P. Gobert, Claire Blanchard-Delaunay, Philippe Ravaud, Pascal Godmer, Xavier Puéchal, Mohamed Hamidou, Hélène Desmurs-Clavel, Pierre-Louis Carron, Elodie Perrodeau, Marize Ducret, Bernard Bonnotte, Thomas Quemeneur, Christian Pagnoux, François Maurier, Benjamin Terrier, Eric Daugas, Luc Mouthon, Nicolas Limal, Loïc Guillevin, A. Karras
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (8), pp.1150-1156. ⟨10.1136/annrheumdis-2017-212768⟩
Annals of the Rheumatic Diseases, 2018, 〈10.1136/annrheumdis-2017-212768〉
Annals of the Rheumatic Diseases, 2018, 77 (8), pp.1150-1156. ⟨10.1136/annrheumdis-2017-212768⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (8), pp.1150-1156. ⟨10.1136/annrheumdis-2017-212768⟩
Annals of the Rheumatic Diseases, 2018, 〈10.1136/annrheumdis-2017-212768〉
Annals of the Rheumatic Diseases, 2018, 77 (8), pp.1150-1156. ⟨10.1136/annrheumdis-2017-212768⟩
International audience; Objective - To compare long-term efficacy of remission-maintenance regimens in patients with newly diagnosed or relapsing antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides. Methods - The 28-month Maintenance
Autor:
Claire Larroche, François Maurier, Gabriel Baron, Michel DeBandt, Benoit De Wazieres, Xavier Mariette, Thomas Quemeneur, Xavier Puéchal, Philippe Ravaud, Raphaèle Seror, Eric Hachulla
Publikováno v:
Annals of the Rheumatic Diseases. 73:2074-2081
Objectives To evaluate the effect of adding a 10-week treatment of adalimumab to a standardised treatment with corticosteroids on the ability to taper more rapidly corticosteroid doses in patients with newly diagnosed giant cell arteritis (GCA). Meth
Autor:
Isabelle Marie, Jean-Marc Léger, Estibaliz Lzaro, Xavier Mariette, Adeline Lacraz, Thomas Quemeneur, Olivier Hermine, Franck Bridoux, Olivier Hinschberger, P. Rullier, Jean-Emmanuel Kahn, Fabrice Carrat, Patrice Cacoub, Thierry Zenone, Christian Pagnoux, P. Belenotti, Fabrice Bonnet, Patricia Senet, Luc de Saint Martin, Guillaume Le Guenno, Antoine Huart, Aurélie Hummel, Evguenia Krastinova, Elisabeth Diot, Benjamin Terrier, Emmanuelle Plaisier, David Launay
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2013, 72 (3), pp.374-80. ⟨10.1136/annrheumdis-2012-201405⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2013, 72 (3), pp.374-80. 〈10.1136/annrheumdis-2012-201405〉
Annals of the Rheumatic Diseases, 2013, 72 (3), pp.374-80. ⟨10.1136/annrheumdis-2012-201405⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2013, 72 (3), pp.374-80. ⟨10.1136/annrheumdis-2012-201405⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2013, 72 (3), pp.374-80. 〈10.1136/annrheumdis-2012-201405〉
Annals of the Rheumatic Diseases, 2013, 72 (3), pp.374-80. ⟨10.1136/annrheumdis-2012-201405⟩
International audience; BACKGROUND: Data on the prognosis of non-infectious mixed cryoglobulinaemia vasculitis (CryoVas) in the era of hepatitis C virus screening are lacking. METHODS: The French multicentre and retrospective CryoVas survey included
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf6b4ef6e610acfb5084c332abcce0c7
https://hal.univ-brest.fr/hal-00935851
https://hal.univ-brest.fr/hal-00935851
Autor:
Matthieu Groh, Christian Pagnoux, Arsène Mekinian, Gabriel Baron, Benjamin Terrier, Eric Liozon, L. Guillevin, Antoine Néel, Boris Bienvenu, Xavier Puéchal, Anne-Marie Ruppert, Christian Agard, Loïk Geffray, Pascal Godmer, A. Bourgarit-Durand, C. Le Jeunne, Thomas Quemeneur, L. Mouthon, T. Papo, Nicolas Limal, P. Ravaud, François Lifermann, Marc Ruivard
Publikováno v:
Annals of the Rheumatic Diseases. 75:77.2-77
Background Glucocorticoids (GC) achieve remission in most patients with systemic necrotizing vasculitides (SNVs) without poor-prognosis factors based on the 1996 Five-Factor Score. However, more than a third of them relapse, mainly during the first 2
Autor:
P. Cohen, Christian Pagnoux, Olivier Decaux, L. Guillevin, Xavier Puéchal, Chahéra Khouatra, L. Mouthon, François Maurier, Pascal Godmer, A. Karras, P. Gobert, Thomas Quemeneur, Groupe français d’étude des vascularites, H. Demurs-Clavel, Benjamin Terrier, O. Aumaître
Publikováno v:
Annals of the Rheumatic Diseases. 72:A124.2-A124
Background The prospective, randomized, controlled MAINRITSAN trial compared rituximab (RTX) to azathioprine (AZA) to maintain ANCA-associated vasculitis (AAV) remission. Once remission was obtained with a conventional regimen, patients were randomly